Combination Therapy of Alpha-Lipoic Acid, Gliclazide and Ramipril Protects Against Development of Diabetic Cardiomyopathy via Inhibition of TGF-β/Smad Pathway
2022Frontiers in PharmacologyJournalOpen access
10.3389/fphar.2022.850542Full text18 citations